CBD YOU CAN TRUST - SEED TO CONSUMER - CSE:SWEL - Sativa Wellness Group
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
CSE:SWEL SEED TO CONSUMER CBD YOU CAN TRUST
DISCLAIMER
This confidential presentation (together with the investment activity may expose an individual to a significant representatives nor any other person accepts any liability forward-looking statement, whether as a result of new
accompanying oral presentation, “Presentation”) is being risk of losing all of the property or other assets invested. whatsoever for any errors, omissions or inaccuracies in such information, future developments or otherwise, except as
provided to you (the “Recipient”) by Sativa Wellness Group Whilst the Presentation has been prepared in good faith, no information or opinions or for any loss, cost or damage required by applicable law or regulation. The Presentation
Inc. (the “Company”) for information purposes only. This representation or warranty, express or implied, is given by or suffered or incurred howsoever arising, directly or indirectly, may have been sent to you in an electronic form. You are
Presentation does not constitute and has not been approved on behalf of the Company, its respective directors and from any use of this Presentation or its contents or reminded that documents transmitted via this medium may
by an authorised person as, a "financial promotion" within affiliates or any other person as to the accuracy or otherwise in connection with its subject matter. You should be altered or changed during the process of electronic
the meaning in section 21 of the Financial Services and completeness of the information or opinions contained in always seek your own independent advice about investment transmission. You are responsible for protecting against
Markets Act 2000. This Presentation is not a prospectus or this Presentation and no responsibility or liability whatsoever and tax matters from a suitably qualified and authorised viruses and other destructive items. Your receipt of this
an admission document or an advertisement and does not is or will be accepted by the Company, its directors and independent financial adviser. You should note that neither electronic transmission is at your own risk and it is your
constitute or form part of, and should not be construed as, affiliates or any other person for any loss howsoever arising, the Company nor any of its members, directors, officers, responsibility to take precautions to ensure that it is free
an offer or invitation to sell or any solicitation of any offer to directly or indirectly, from any use of such information or employees, agents or representatives is authorised to give from viruses and other items of a destructive nature. As a
purchase or subscribe for any common shares of the opinions or otherwise arising in connection therewith. Any tax or financial advice. Nothing in this Presentation is, or consequence of the above, neither the Company nor any
Company (“Shares”) in any jurisdiction. Such an offer and such liability is expressly disclaimed, save that nothing in should be relied on as, a promise or representation as to the director, officer, employee or agent of any of them or any
solicitation only may be made pursuant to the private this Presentation Disclaimer shall be effective to limit or future. This Presentation contains forward-looking affiliate of any such person accepts any liability or
subscription documents and other applicable documents exclude any liability for fraud or which otherwise cannot, by statements” or “forward-looking information” within the responsibility whatsoever in respect of any difference
(the “Operative Documents”), which should be read in their law or regulation, be so limited or excluded. The promotion meaning of applicable securities laws (collectively, “forward- between the document distributed to you in electronic
entirety. The statements in this Presentation are not of Shares and the distribution of this Presentation in the looking statements”), which reflect the views of the format and the hard copy version that may be made
intended to be complete or final and are qualified in their United Kingdom and elsewhere are restricted by law. Company with respect to, among other things, the available to you.
entirety by reference to the Operative Documents. In the Accordingly, you must not copy, publish or distribute this Company’s operations. These forward-looking statements
event that the descriptions or terms described herein are Presentation in any way or to any person in or into any are identified by the use of words such as “believe”, “expect”, Resale Restrictions: The securities described herein are
inconsistent with or contrary to the descriptions in or terms jurisdiction. The Company is not responsible to the “potential”, “continue”, “may”, “will”, “should”, “seek”, being offered on a private placement basis in reliance upon
of the Operative Documents, the Operative Documents shall Recipient for providing regulatory and legal protections “approximately”, “predict”, “intend”, “plan”, “estimate”, prospectus and registration exemptions under applicable
control. Therefore, any recipient hereof should read the afforded to customers (as defined in the rules of the “anticipate” or other comparable words. These forward- securities legislation. Resale of the securities offered hereby
Operative Documents and should conduct its own Financial Conduct Authority) nor for providing advice in looking statements are subject to various risks, uncertainties will be subject to restrictions under applicable securities
independent analysis of the date referred to herein. Neither relation to the contents of this Presentation on any matter, and assumptions. There are or will be important factors that legislation, which will vary depending on the relevant
the Presentation, nor any part of it nor anything contained or transaction or arrangement referred to in it. Neither the could cause actual outcomes or results to differ materially jurisdiction. Generally, such securities may be resold only
referred to in it, nor the fact of its distribution, should form Company nor any of its directors, officers or employees from those indicated in these statements. Should any pursuant to an exemption from the prospectus and
the basis of or be relied on in connection with or act as an makes any representation or warranty, express or implied, as assumptions underlying the forward-looking statements registration requirements of applicable securities legislation
inducement in relation to a decision to purchase or to the accuracy or completeness of the information or contained in this Presentation prove to be incorrect, the or pursuant to an exemption order granted by appropriate
subscribe for or enter into any contract or make any other opinions contained in this Presentation. To the fullest extent actual outcome or results may differ materially from securities regulatory authorities.
commitment whatsoever in relation to any Shares. Reliance permitted by law, neither the Company nor any of its outcomes or results projected in these statements. The
on this Presentation for the purpose of engaging in any members, directors, officers, employees, agents or Company is under no obligation to update or review any
2 / 30
CSE:SWEL
THE #1 CONSUMER
While other companies
CONCERN IS claim to "control the
TRUST AND supply chain," Sativa
owns the entire supply
SAFETY IN THEIR chain.
CBD PRODUCTS
THE SATIVA DIFFERENCE
3 / 30
CSE:SWEL
THE SATIVA DIFFERENCE
SEED TO CONSUMER
INTEGRATION
Extraction
Proprietary extraction Manufacturing Sales Channels
techniques that set the State of the art product Retail and wholesale
standard for quality. development and white channels designed for
labeling services. today's fast evolving
consumer expectations.
Cultivation Quality Control Brands
By far the largest hemp The UK’s premier testing A portfolio of unique
cultivator in Poland and one facility for CBD and hemp- brands tailored to key
of the largest in Europe. based products. consumer demographics.
4 / 30
CSE:SWEL
3 out of 4 consumers report that CBD use has positively
impacted their lives while 65% of current CBD users are likely
to buy CBD again in the next 6 months.
MARKET OPPORTUNITY
THE EUROPEAN CBD 16% of Europeans ages 18
and over have tried CBD
MARKET IS EXPECTED 18% of non-consumers report
TO GROW 400% BY
that they are likely to try CBD
in the next 6 months
2023 WITH A TOTAL
Source: www.healtheuropa.eu/applying-data-address-europes-burgeoning-cbd-market/98012/
VALUE OF $1.7 BILLION Non-consumers list factors like product quality and being
able to ask for advice on products among the top reasons
influencing their potential CBD purchases.
Source: www.brightfieldgroup.com/press-
releases/europe-cbd-market-through-2023
More than half (55%) of the EU’s
general population is interested
in learning more about CBD
5 / 30
Recent FDA product testing
showed that only 45% of
products contained the
SAFETY AND TRUST amount of CBD as
advertised, and 49% of all
products tested had higher
A BOOMING than allowable levels of
THC. Even more surprising
A low barrier of entry has
led to over 1,000 retail
UNREGULATED was that many brands
contained no CBD
brands in the CBD space.
Many of them formulate in
INDUSTRY whatsoever, while some
others also tested positive
kitchens, garages and
basements and have little
for toxic substances. or no product control.
“FDA WARNS 15 COMPANIES “WHAT'S IN YOUR CBD?
“CBD LABELING WHAT “FEARS TOXIC CANNABIS FOR ILLEGALLY SELLING BUYER BEWARE”
YOU SEE IS NOT ALWAYS POLLUTED IN CHINA COULD
VARIOUS CBD PRODUCTS”
WHAT YOU GET” FLOOD UK SEED MARKET”
Read Article Read Article Read Article Read Article
6 / 30
CSE:SWEL
SAFETY AND TRUST
Complete control of the entire state-of-the-art cannabis testing
THE SATIVA supply chain from seed to consumer laboratories, established brands,
is the only way to produce consistent, and existing wholesale and retail
ANSWER high-quality products. With the
cultivation and extraction of all
sales channels Sativa Wellness is
well-positioned to thrive in a
cannabinoids, fully operational mature, more regulated market.
Complete traceability of all All processes performed All products thoroughly
cannabinoids from seed to in certified, safe, state-of- laboratory tested for
consumer the-art facilities consistency, purity and safety
Pending government legislation on labelling and product
testing will reduce the number of brands significantly.
7 / 30
CSE:SWEL
CULTIVATION
IT STARTS WITH
A SEED
Current Unregulated Industry The Sativa Difference
Hemp modified seeds, fertilizers, Hemp grown exclusively on
and pesticides in untested soil. certified organic land tested to
Hemp biomass with illegal THC be free of heavy metals,
levels, pesticides, and heavy pesticides, and within legal THC
metals make it in to the limits.
production cycle and onto the Testing of biomass in certified
shelves. laboratories during growth and
Recent testing has shown "most after harvest.
of the cultivars and biomass Tracking of biomass through
grown using most of the chain of custody from our fields
varieties that we're currently to consumers' homes. Sativa is ahead of the
using in the U.S. would no longer expected global
be defined as hemp." agriculture testing and
compliance standards.
8 / 30
CSE:SWEL
EXTRACTION
EXTRACTING PURE
EXCELLENCE
Current Unregulated Industry The Sativa Difference
Sativa is ahead of the anticipated
global legislation on certification Many small and sizeable Initial extraction using grain
and health requirements for unlicensed extraction facilities alcohol in a licensed, inspected
cannabinoid extraction facilities. are using carcinogenic solvents facility adhering to food safety
as their primary method, standards under Hazard Analysis
including Butane and Benzene. and Critical Control Point (HACCP)
Unregulated and unlicensed certification.
extraction facilities do not Tracking and laboratory testing of
mandate mandatory product the product in every step of the
testing throughout the extraction process from biomass to finished
process and have no certifiable CBD.
standard operating procedures. Resulting in a safe, pure,
This results in impure, untested consistent product in consumers'
products in consumers' hands, hands.
which are mislabeled and
potentially even dangerous.
9 / 30
CSE:SWEL
TESTING & MANUFACTURING
MANUFACTURING &
QUALITY CONTROL
Current Unregulated Industry The Sativa Difference
Of the thousands of brands of Testing of all products for purity,
CBD, only a handful make their safety and consistency in our
own consumer products, own industry-recognized,
many smaller players mix and certified laboratory, PhytoVista.
bottle in non-sterile kitchen, State-of-the-art food-safe
garages and basements with bottling facility which formulates
no required testing. Sativa brands as well as
Only a few CBD providers provides white-label services to
laboratory test their finished other brands.
products before selling to an
unsuspecting consumer. Sativa is ahead of the anticipated
Less than 50% of industry global legislation on testing and health
products provide what is requirements for a Cannabinoid
promised on the label. formulation and packaging facility.
10 / 30
CSE:SWELBRANDS
BRANDS YOU
CAN TRUST
Current Unregulated Industry The Sativa Difference
A large number of unregulated and Products that meet or exceed current
unlicensed products sold through regulations with advanced stage Novel
the Internet make illegal health Food licencing (a requirement in many
claims about their product. E.U. countries past March 2021)
There is still no clear brand Ownership of some of the most
leader, while many products recognized brands in Europe with retail
have no physical presence and presence and distribution in place.
sell online only. Owning the entire supply chain enables
High product cost equates to high the lowest possible cost of goods in
retail cost, CBD becomes the industry and can be used to price a
unaffordable for many consumers. competitive advantage in the
marketplace.
11 / 30
CSE:SWELWHOLESALE
FROM A TRUSTED
SOURCE
Current Unregulated Industry The Sativa Difference
In an unregulated marketplace, Fully compliant cannabis
we are seeing untested, impure cultivation and those of
bulk CBD sold globally. In Europe approved agricultural partners
only CBD from European produce legal and traceable
approved hemp is legally wholesale CBD products.
allowed to be sold. CBD products that are
Many companies are buying compliant with all European
Chinese and American bulk CBD laws from seed to consumer
and passing it off as European As governments begin to
product. enforce current regulations
Many larger established Sativa will benefit through its
businesses investigate bulk current and ongoing
"chain of custody" to assure they compliance
are purchasing a compliant
product.
12 / 30
CSE:SWELRETAIL
OWNED SALES
CHANNELS
Current Unregulated Industry The Sativa Difference
Loose and unenforced packaging Consumer confidence in
requirements lead to inferior recognized, stable brands with
products on the shelf. retail outlets and distribution in
Many products have no testing, well-known pharmacies, wellness
no return policy, and no stability and retail outlets.
as brands come and go daily. Addressing the move towards the
preference for online purchasing,
we have launched
goodbodystore.com. The e-
commerce site houses Goodbody
and supplementary brands
through an innovative "Pillars"
structure designed to flow
consumers to areas of need.
Our flagship store is set up for a
franchise model with scalable
13 / 30
CSE:SWEL infrastructure.2020-2021 CATALYSTS
Sativa, from lessons learned in 2019, has taken
a diversified approach to agriculture:
2020-2021 CATALYSTS
CULTIVATION • Along with our own certified
organic crops, we've
• The company expects to have
access to 450,000 kilos of
partnered with hemp growers high-grade biomass with a
throughout Europe. gross CBD content of 225
million grams.
• This multipronged approach • The company has to date
reduces or eliminates secured more high-quality
agricultural risk while assuring biomass than any in Europe at
the highest quality certified very competitive pricing.
CBD biomass available in
Europe.
15 / 30
CSE:SWEL2020-2021 CATALYSTS
Proprietary extraction techniques that
set the standard for quality.
EXTRACTION
• Two completed extraction • We believe Kosher, HACCP,
facilities: Origin in Romania and Novel Foods
and Nexus in Poland, are each certifications combined with
capable of producing up to already low production costs
1000 finished Kilos of CBD will enable us to dictate the
monthly. bulk pricing of CBD in Europe.
• The company feels combined
with its cost of biomass and
cost of manufacturing it will
be able to produce the lowest
cost CBD in Europe.
16 / 30
CSE:SWELIt is anticipated that mandatory testing will become
one of the most significant single global events across
the cannabis industry.
• Sativa's Phytovista laboratory • Additionally, Sativa has
is already a recognized, ownership of its laboratory, so
trusted and certified our owned brands receive
2020-2021 CATALYSTS
laboratory to the cannabis priority testing enabling us to
QUALITY CONTROL industry in Europe. bypass potential backlogs and
minimize costs.
• With product testing expected
to become mandatory, Sativa
expects to see a substantial
increase in testing enquiries
and business.
17 / 30
CSE:SWELThe majority of brands do not formulate their
own products or own anything. They come to
companies like Sativa for their product.
2020-2021 CATALYSTS
• As Novel Food certification is • Now, with the ability to offer
required for many countries
beyond March 2021 only a
third-party clients all services
from seed to consumer in a
MANUFACTURING
handful of manufacturers like compliant, low-cost, and safe
Sativa will be able to offer this manner, the company expects
certification. increased manufacturing
revenue that generally goes
• The company anticipates a hand in hand with its White
sharp increase in white label Labelling.
orders, as brands will start to
seek compliant
manufacturers to keep their
brands on the shelf.
18 / 30
CSE:SWELProduct Line Expansion:
2020-2021 CATALYSTS
BRANDS • Alongside our recently
launched CBD oils with
• The product range will also
enable us to strengthen our
Vitamin D, there are plans wellness offering for
to expand the product marketing collateral.
range further.
• The expansion of the
product range will ensure
that we have the biggest
range on offer to retailers
and consumers UK wide.
19 / 30
CSE:SWEL2020-2021 CATALYSTS
SALES CHANNELS
Focus: Accelerating Online Growth
TRIAL CBD CBD YOU CAN TRUST BRAND STRATEGY PRODUCT/PRICING
STRATEGY
Testing, CBD Education Case studies, Research Botanicals:
Papers, Reviews, Pharmaceuticals Content, Promotions, Target
Professional Bodies Wellness/Hemp: Health Audiences, Competitors,
clubs, spas Cross Promote
AFFILIATES ONLINE SOCIAL OFFLINE SEO/PPC ASSOCIATIONS/
ADVERTISING TO ONLINE EXPERIENTIAL
• Affiliate Scheme • Facebook • SEO
• Amazon • Programmatic • Instagram • Press ads • Blogger • Like minded target
• eBay • Banners • Twitter • Advertorials • PPC market associations
• Groupon • Guest Blogging • Snapchat • PR • Display adverts • Forums
• Discount Sites • 3rd Party Advertising • Pinterest • Sponsorships • Subscriptions • Events with high
• Promo Sites • YouTube • Influencer • OOH footfall
• Retargeting • LinkedIn • 3rd party
• Email mktg/lists • On pack
• Word of mouth
20 / 30
CSE:SWEL2020-2021 CATALYSTS
WHOLESALE
Owning the entire supply chain from seed, Sativa
will see one of its most significant benefits in the
bulk CBD business:
• Sativa in unaware of any other • With the lowest costs in all
company in the industry that phases of CBD production, the
owns the entire supply chain. company feels it will be able
They may claim they control it to dictate the pricing of bulk
through third-party contracts, CBD and become one of
but this is far different than Europe's leading suppliers.
outright ownership.
21 / 30
CSE:SWEL2020-2021 CATALYSTS While concentrating on organic Although the company has
growth, the company also concentrated in CBD, it does
MERGERS AND intends to leverage its strong
position to look at growth
have a medical THC handling
permit and does grow a
ACQUISITIONS
through acquisitions. The relatively small amount of
company feels the current marijuana for medical research
global cannabis economy, purposes. Should the business
along with the emergence of opportunity arise and make
COVID-19, has created some sense, the company may
well-priced opportunities. increase its involvement in the
medical marijuana space.
22 / 30
CSE:SWELPEER COMPARABLES
Company CULTIVATION EXTRACTION LABORATORY MANUFACTURING BRANDS SALES CHANNELS
Wholesale Retail
Sativa Wellness
Dragonfly
Charlotte’s Web
Mile High Labs
Isodiol
Endoca
CV Science
* based on publically available information
23 / 30
CSE:SWELLICENCING STRATEGY
POCA
Industrial Hemp 3 Year Research Research & Proceeds of ISO Accreditation Novel Food Application
Low THC ( 0.2%) standard for testing and • Product formulation and • Genotoxicity study
calibration laboratories specification • Sub chronic toxicity
• Production process study
(SOPs) • Stability testing
• Absorption, distribution, • History of use and
metabolism and proposed usage
excretion (ADME)
Engaged with:
24 / 30
CSE:SWELLEADERSHIP TEAM
BOARD OF DIRECTORS
HENRY LEES-BUCKLEY JOSEPH COLLIVER
JONATHAN WEARING
Chief Executive Officer Chief Financial Officer
Non-Executive Chairman
JASON DUSSAULT ANGUS KERR MARK BLOWER
Non-Executive Director, Non-Executive Director Non-Executive Director
Corporate Communications
ANNE TEW
Corporate Secretary
25 / 30
CSE:SWELCOMBINED SHARE STRUCTURE
STILLCANNA
Undiluted Issued and Outstanding 111,874,727*
Outstanding Warrants (Average strike price $1.40) 15,174,425*
Outstanding Options 3,635,000*
SATIVA WELLNESS
Undiluted Issued and Outstanding 190,720,026
Outstanding Warrants (Average strike price $xx) 10,328,631 (Average strike price = $0.25)
Outstanding Options 39,793,377
Fully Diluted Issued & Outstanding 371,526,206
26 / 30
CSE:SWELTel: 02079711255 The Blue Building
enquiries@ Stubbs Lane
sativawellnessgroup.com Beckington, BA11 6TE
CSE:SWELAPPENDIX
BOARD DIRECTOR BIOS
JONATHAN WEARING JOSEPH COLLIVER ANNE TEW ANGUS KERR
Non-Executive Chairman CFO Company Secretary Non-Executive Director
Jonathan joins as non-Executive Chairman. Joseph is a qualified Chartered Accountant with Anne is an experienced Accountant, Corporate Angus is an adviser and capital markets
Jonathan is an experienced, City-based corporate significant commercial finance experience. Before Secretary and professional business mentor with professional with nearly 25 years’ experience in
financier, who began his City career after graduating joining Sativa, Joseph was a Director of Consulting at over 30 years’ experience across a range of global banking with specific expertise in strategic
from Cambridge University with a M.A. in Kantar Consulting, part of WPP plc (“WPP”) which industries including the NHS, testing laboratories, and equity advisory, M&A and ECM. He has held,
Economics. He was Chairman of Ideagen plc on its advises Retail, Sales and Shopper clients on manufacturing and farming. She has successfully inter alia, managing director and management
admission to the AIM market in July 2012 until April enhancing their commercial capability and the led projects to achieve business turnaround, roles covering advisory, equity advisory and ECM
2018. Following eight years in Citibank London’s commercial competency of their staff. Prior to this, restructuring, growth and development. Anne has at a number of organisations, including head of
corporate banking division, providing debt finance Joseph was Chief Financial Officer and a senior worked as an Executive and Non-Executive Director Mid-Market Advisory and Broking at Credit
board member at WPP’s Kantar Futures, which as well as advising board members in financial and Suisse and head of UK ECM Dresdner Kleinwort.
for growth and acquisition purposes, he moved to
advises its clients on enhancing profit through governance matters as the Corporate Secretary or He has a long track record of advising
Citicorp’s London investment bank (CIBL) where, as
change and shaping strategy. Here, Joseph was as an external consultant. companies and high-profile individuals in the UK,
a Director in the Corporate Finance Department, he
accountable for financial performance, managing a USA and Europe. Prior to his career in finance
worked on both UK and cross-border transactions. global finance team. From 2012-2015 Joseph was Angus was an Army Officer. Angus has a BA
Global Commercial Director of WPP’s Kantar MARK BLOWER (Hons) in Politics and International Relations
subsidiary Taylor Nelson Sofres, a $1.8 billion Non-Executive Director from the University of Reading.
HENRY LEES-BUCKLEY turnover marketing agency.
CEO Mark is an experienced finance professional, having
spent the last 20 years actively overseeing the
Chief Executive Officer of Sativa Group PLC, is a financial performance of over 70 UK SME’s, with a
seasoned corporate executive, with extensive JASON DUSSAULT
Non-Executive Director, Corporate Communications particular focus on raising debt and private equity.
experience of leading companies in the public He began his career in 1996 at the Investment
markets. Henry was previously CEO of Uni-Select A multi-talented man, known for his innovative Banking division of a large UK bank, before joining
[TSX:UNS], a Canadian TSX quoted company, with marketing style, and as an accredited artist.A man of NM Rothschild in 2000. He then ran a highly
operations in the UK, Canada and the USA. Prior to great accomplishments, he was the star and successful leveraged debt team for another UK
that, he was a senior global executive and officer in producer of the Dussault Inc. a City TV reality show. lending institution for five years before starting his
the USA and Canada for W.W. Grainger, a US$15 Dussault has received significant media attention on Private Equity career in 2010. During his career to-
billion market capitalisation Fortune 500 company. FOX NEWS, Entertainment Tonight, CityTV, ETalk on date he has held a number of board positions,
Henry is currently a non-Executive Director of CTV, CBC, MTV, The Wall Street Journal and New across a variety of sectors.
NASDAQ-quoted BMC (Building Materials Corp) York Times to name a few. Jason is well versed in
[NASDAQ:BMCH] which has sales of US$3.8 billion the capital markets and mining, with decades of
and a market capitalisation of US$1.6 billion. Henry experience in the North West Territories diamond
holds an MBA from Queens University, Kingston, boom. Over the past several years he has pushed the
Ontario and has held numerous executive level global frontier in the Cannabis marketplace as CEO of
positions both in North America and the United Stillcanna Inc. a Canadian public company focused
Kingdom.
on manufacturing CBD in Europe. He raised over 30
million dollars, built large extraction facilities in
Romania and Poland, built an experienced global
team and negotiated significant strategic alliances
29 / 30
including the merger with Sativa.
CSE:SWELGOODBODY BOTANICALS PRODUCTS
CBD Oil Peppermint Peppermint CBD CBD Oil
5% (500mg) CBD Oil Oil 2.5% (250mg)
20% (2000mg) 15% (1500mg)
CBD Oil CBD Soft gels CBD Balm CBD Gummies
10% (1000mg) 30 x 10mg 1% (300mg) 14 x 10mg
30 / 30
CSE:SWELGOODBODY WELLNESS VITAMIN D RANGE
Orange and
Lemons with
Vitamin D CBD Oil
Peppermint with
Vitamin D CBD Oil
31 / 30
CSE:SWELYou can also read
